189 related articles for article (PubMed ID: 16007190)
21. Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats.
Ohara H; Akatsuka S; Nagai H; Liu YT; Jiang L; Okazaki Y; Yamashita Y; Nakamura T; Toyokuni S
Free Radic Res; 2011 Feb; 45(2):211-20. PubMed ID: 20942562
[TBL] [Abstract][Full Text] [Related]
22. Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha.
Barbier O; Girard H; Inoue Y; Duez H; Villeneuve L; Kamiya A; Fruchart JC; Guillemette C; Gonzalez FJ; Staels B
Mol Pharmacol; 2005 Jan; 67(1):241-9. PubMed ID: 15470081
[TBL] [Abstract][Full Text] [Related]
23. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization.
Stassar MJ; Devitt G; Brosius M; Rinnab L; Prang J; Schradin T; Simon J; Petersen S; Kopp-Schneider A; Zöller M
Br J Cancer; 2001 Nov; 85(9):1372-82. PubMed ID: 11720477
[TBL] [Abstract][Full Text] [Related]
24. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
[TBL] [Abstract][Full Text] [Related]
25. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma.
Zhong Y; Onuki J; Yamasaki T; Ogawa O; Akatsuka S; Toyokuni S
Carcinogenesis; 2009 Jan; 30(1):158-64. PubMed ID: 19028700
[TBL] [Abstract][Full Text] [Related]
27. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
[TBL] [Abstract][Full Text] [Related]
28. Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas.
Heikaus S; Casliskan E; Mahotka C; Gabbert HE; Ramp U
Apoptosis; 2007 Sep; 12(9):1645-57. PubMed ID: 17610067
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
[TBL] [Abstract][Full Text] [Related]
30. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
[TBL] [Abstract][Full Text] [Related]
31. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
32. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.
Yuan J; Takahashi A; Masumori N; Itoh N; Tsukamoto T
Int J Urol; 2006 Mar; 13(3):265-70. PubMed ID: 16643621
[TBL] [Abstract][Full Text] [Related]
34. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1.
Eeckhoute J; Briche I; Kurowska M; Formstecher P; Laine B
J Mol Biol; 2006 Dec; 364(4):567-81. PubMed ID: 17022998
[TBL] [Abstract][Full Text] [Related]
36. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
[TBL] [Abstract][Full Text] [Related]
37. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA
Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166
[TBL] [Abstract][Full Text] [Related]
38. Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma.
Brito GC; Fachel AA; Vettore AL; Vignal GM; Gimba ER; Campos FS; Barcinski MA; Verjovski-Almeida S; Reis EM
Mol Carcinog; 2008 Oct; 47(10):757-67. PubMed ID: 18348187
[TBL] [Abstract][Full Text] [Related]
39. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
40. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.
Rebouissou S; Vasiliu V; Thomas C; Bellanné-Chantelot C; Bui H; Chrétien Y; Timsit J; Rosty C; Laurent-Puig P; Chauveau D; Zucman-Rossi J
Hum Mol Genet; 2005 Mar; 14(5):603-14. PubMed ID: 15649945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
